Journal profile · PERIPHERAL VASCULAR DISEASE
Clinica e Investigacion en Arteriosclerosis
ISSN 0214-9168 · eISSN 1578-1879 · Elsevier
Clinica e Investigacion en Arteriosclerosis: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.9 (journal website); hybrid open access; APC about USD 1,940; median 53 days to acceptance (76 articles, last 24 months); 39 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Clinica e Investigacion en Arteriosclerosis is published by Elsevier and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins and Atherosclerosis and Cardiovascular Diseases, together about 42.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Clínica e Investigación en Arteriosclerosis is the official journal of the Spanish Society of Arteriosclerosis, the Latinoamerican Society of Arteriosclerosis and the Iberolatinoamerican Society of Arteriosclerosis. The journal is the leading Spanish written peer-review journal in the field of arteriosclerosis and its related risk factors. The aim of the journal is primarily the promotion of knowledge and continued medical education, with a special focus in the Spanish-speaking audience, through the publication of relevant research contributions, basic and clinical, in the field and the publication of review and update articles.Clínica e Investigación en Arteriosclerosis es la publicación oficial de la Sociedad Española de Arteriosclerosis, la Sociedad Latinoamericana de Arteriosclerosis y la Sociedad Iberolatinoamericana de Arteriosclerosis. Uno de sus principales objetivos la investigación y la información actualizada sobre la arteriosclerosis y las alteraciones afines a esta patología. La revista tiene carácter multidisciplinario y se ocupa tanto de los aspectos de las ciencias básicas como de la etiología, epidemiología, fisiopatología, diagnóstico y tratamiento de la arteriosclerosis y procesos relacionados. Igualmente, publica trabajos de investigación (originales y comunicaciones breves) y de formación continuada o actualización (revisiones).
From the journal's Aims & Scope
Research area (LetPub): PERIPHERAL VASCULAR DISEASE
Editorial board by country: none in mainland China; most named Spain 16, Brazil 3, Colombia 3 (22 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lipoproteins and Cardiovascular HealthMedicine19.7%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine17.7%
- Atherosclerosis and Cardiovascular DiseasesImmunology and Microbiology5%
- Adipokines, Inflammation, and Metabolic DiseasesMedicine4.9%
- Health and Lifestyle StudiesHealth Professions4.7%
- Blood Pressure and Hypertension StudiesMedicine4.1%
- Cholesterol and Lipid MetabolismMedicine3.5%
- Lipid metabolism and disordersMedicine3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1.9Publisher website ·
- CiteScore 2026-06
- 2.9LetPub ·
- CiteScore (publisher)
- 2.9Publisher website ·
- SJR 2026-06
- 0.44LetPub ·
- SNIP 2026-06
- 0.56LetPub ·
- h-index
- 29OpenAlex ·
- i10-index
- 124OpenAlex ·
- 2-year mean citedness
- 0.72OpenAlex ·
- Self-citation rate
- 10.5%LetPub ·
- Share of gold OA articles
- 28.85%LetPub ·
Volume
- Articles per year
- 34LetPub ·
Articles by year OpenAlex count · 1,458 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 34 | 7 | 5 |
| 2025 | 39 | 11 | 21 |
| 2024 | 54 | 26 | 66 |
| 2023 | 34 | 10 | 97 |
| 2022 | 46 | 8 | 224 |
| 2021 | 62 | 16 | 311 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
53 daysMedian, submission to acceptance · P25–P75 21 days – 79 days
- Acceptance to online
- median 27 days (74 articles)
- Submission to online
- median 90 days
- Sample
- 76 articles with submission and acceptance dates (113 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- First decision after review
- 42 daysPublisher website ·
- Submission to acceptance
- 55 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 1,940 / EUR 1,770 / GBP 1,550 / JPY 240,620 | — | — | |
| Publisher website | USD 2,365 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted9
- clinical notesClinical NotesDescription of one or more clinical cases of exceptional observation that make an important contribution to the knowledge of cardiovascular diseas…Length not stated
- editorialThe Journal contains the following sections:OriginalsBasic and /or clinical research works related to arteriosclerosis and its risk factors, including those con…Length not stated
- editorialsThe Journal also includes Editorials, Reviews, Special Articles and Literature Reviews, which will be commissioned by the Editorial Team, who will indicate the …Length not stated
- literature reviewsThe Journal also includes Editorials, Reviews, Special Articles and Literature Reviews, which will be commissioned by the Editorial Team, who will indicate the …Length not stated
- originalsOriginalsBasic and /or clinical research works related to arteriosclerosis and its risk factors, including those conducted in experimental animal models.. A max…Length not stated
- reviewThe Journal contains the following sections:OriginalsBasic and /or clinical research works related to arteriosclerosis and its risk factors, including those con…Length not stated
- reviewsThe Journal also includes Editorials, Reviews, Special Articles and Literature Reviews, which will be commissioned by the Editorial Team, who will indicate the …Length not stated
- short originalsShort OriginalsInvestigation works that, due to their special characteristics (reduced number of observations, preliminary results of special relevance, descrip…Length not stated
- special articlesThe Journal also includes Editorials, Reviews, Special Articles and Literature Reviews, which will be commissioned by the Editorial Team, who will indicate the …Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- Authorship Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Source ↗Publisher website ·- Conflicts of interest Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…
Source ↗Publisher website ·- License & copyright Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Subscribers may reproduce tables of contents or prepare lists of articles includ…
Source ↗Publisher website ·- Open access Open access
12-month embargo Model summary
Please visit our Open Access page for more information about open access publishing in this journal.This journal has an embargo period of 12 months.
Source ↗Publisher website ·- Peer review
Double anonymized review Model summary
This journal uses double anonymized review, which means the identities of the authors are concealed from the reviewers, and vice versa.
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- ISSN
- 0214-9168
- Electronic ISSN
- 1578-1879
- Society / sponsor
- Spanish Society of Arteriosclerosis
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Clinica e Investigacion en Arteriosclerosis
What CAS zone is Clinica e Investigacion en Arteriosclerosis in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinica e Investigacion en Arteriosclerosis is in Zone 4 of Medicine, and in Zone 4 of the minor category Peripheral Vascular Disease. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinica e Investigacion en Arteriosclerosis?
The journal's website gives an impact factor of 1.9; this is the journal's own figure, as LetPub lists none for it; CiteScore 2.9, h-index 29.
How long does peer review take at Clinica e Investigacion en Arteriosclerosis?
Based on the dates recorded on 76 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 53 days (interquartile range 21–79 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Clinica e Investigacion en Arteriosclerosis based?
Of the 22 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Spain (16), Brazil (3) and Colombia (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Clinica e Investigacion en Arteriosclerosis?
According to LetPub and DOAJ records, Clinica e Investigacion en Arteriosclerosis is indexed in ESCI and Scopus. The journal's website also lists PubMed; that list has not been checked against each database.
Is Clinica e Investigacion en Arteriosclerosis open access, and what is the APC?
Clinica e Investigacion en Arteriosclerosis is a hybrid journal. For open-access publication: APC about USD 1,940.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .